These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19798121)

  • 1. Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor.
    Tseng JC; Granot T; DiGiacomo V; Levin B; Meruelo D
    Cancer Gene Ther; 2010 Apr; 17(4):244-55. PubMed ID: 19798121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models.
    Tseng JC; Hurtado A; Yee H; Levin B; Boivin C; Benet M; Blank SV; Pellicer A; Meruelo D
    Cancer Res; 2004 Sep; 64(18):6684-92. PubMed ID: 15374985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG; Li JJ; Hu P; Lei L; Wang JN; Liu RB
    Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.
    Currier MA; Eshun FK; Sholl A; Chernoguz A; Crawford K; Divanovic S; Boon L; Goins WF; Frischer JS; Collins MH; Leddon JL; Baird WH; Haseley A; Streby KA; Wang PY; Hendrickson BW; Brekken RA; Kaur B; Hildeman D; Cripe TP
    Mol Ther; 2013 May; 21(5):1014-23. PubMed ID: 23481323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer.
    Matuszewska K; Santry LA; van Vloten JP; AuYeung AWK; Major PP; Lawler J; Wootton SK; Bridle BW; Petrik J
    Clin Cancer Res; 2019 Mar; 25(5):1624-1638. PubMed ID: 30206160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.
    Bourgeois-Daigneault MC; St-Germain LE; Roy DG; Pelin A; Aitken AS; Arulanandam R; Falls T; Garcia V; Diallo JS; Bell JC
    Breast Cancer Res; 2016 Aug; 18(1):83. PubMed ID: 27503504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody.
    Yu M; Scherwitzl I; Opp S; Tsirigos A; Meruelo D
    J Immunother Cancer; 2019 Jul; 7(1):185. PubMed ID: 31307539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
    Tan G; Kasuya H; Sahin TT; Yamamura K; Wu Z; Koide Y; Hotta Y; Shikano T; Yamada S; Kanzaki A; Fujii T; Sugimoto H; Nomoto S; Nishikawa Y; Tanaka M; Tsurumaru N; Kuwahara T; Fukuda S; Ichinose T; Kikumori T; Takeda S; Nakao A; Kodera Y
    Int J Cancer; 2015 Apr; 136(7):1718-30. PubMed ID: 25156870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
    Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors.
    Granot T; Venticinque L; Tseng JC; Meruelo D
    PLoS One; 2011; 6(6):e20598. PubMed ID: 21674047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy that safely targets and kills tumor cells throughout the body.
    Hurtado A; Tseng JC; Meruelo D
    Rejuvenation Res; 2006; 9(1):36-44. PubMed ID: 16608394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan.
    Granot T; Meruelo D
    Cancer Gene Ther; 2012 Aug; 19(8):588-91. PubMed ID: 22677940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells.
    Saito K; Uzawa K; Kasamatsu A; Shinozuka K; Sakuma K; Yamatoji M; Shiiba M; Shino Y; Shirasawa H; Tanzawa H
    Br J Cancer; 2009 Aug; 101(4):684-90. PubMed ID: 19638980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.
    Mahller YY; Vaikunth SS; Ripberger MC; Baird WH; Saeki Y; Cancelas JA; Crombleholme TM; Cripe TP
    Cancer Res; 2008 Feb; 68(4):1170-9. PubMed ID: 18281493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain.
    Unno Y; Shino Y; Kondo F; Igarashi N; Wang G; Shimura R; Yamaguchi T; Asano T; Saisho H; Sekiya S; Shirasawa H
    Clin Cancer Res; 2005 Jun; 11(12):4553-60. PubMed ID: 15958641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
    Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.